Your Article Summary
See Latest ArticlesMoclobemide in social phobia
European Archives of Psychiatry and Clinical Neuroscience, 05/13/08
Katschnig H - The results indicate that 600 mg of moclobemide per day given b.i.d. is effective in social phobia, reducing the symptoms and the impairment associated with the disorder. The compound is well tolerated and safe.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/18/09
Today in Mental Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Why depression is hard to diagnose
The Clinical Advisor, 12/18/09
The Role of Public Health in Addressing Racial and Ethnic Disparities in Mental Health and Mental Illness
Preventing Chronic Disease, 12/18/09
Evolving Definitions of Mental Illness and Wellness
Preventing Chronic Disease, 12/18/09